Contact us for free information or to start a free case review.
The Food and Drug Administration approved a labeling change for the Ortho Evra birth control patch based on a new study linking the contraceptive to a greater risk of potentially fatal blood clots than the pill.
Ortho Evra is a transdermal patch that releases estrogen and progestin directly through the skin and into the bloodstream, exposing women to about 60 percent more hormone than oral contraceptives.
Greater hormone levels are associated with increased risks of side effects, including the risk of venous thromboembolism (VTE)—a condition that can lead to fatal pulmonary embolism.
In September 2006, the label of Ortho Evra was updated to reflect this increased risk after a study showed that the patch nearly doubled a woman’s risk of VTE. The new study, which was conducted on women between the ages of 15 and 44, supports the earlier findings.
Injured by Ortho Evra? Contact an experienced attorney near you today to learn more about your legal options.
Copyright © 2001 - 2012 Online Lawyer Source
ATTORNEY ADVERTISEMENT—Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer.